ASP Isotopes affiliate Donald George Ainscow plans to sell 50,000 common-stock shares valued at approximately $194,390.65. The notice gives investors the proposed transaction’s size, seller, broker and stated Acquisition basis, identifying the shares as compensation received through a Restricted Stock Award.
Key Highlights
- Donald George Ainscow is identified as an affiliate of ASP Isotopes.
- J.P. Morgan Securities LLC is named as the agent and attorney-in-fact for the transaction.
- The shares were acquired as compensation through a Restricted Stock Award on 08/01/2025.
ASP Isotopes, Inc. (NASDAQ: ASPI) has a proposed sale of 50,000 common-stock shares valued at approximately $194,390.65 by affiliate Donald George Ainscow. The filing lists September 2, 2026, and identifies J.P. Morgan Securities LLC in connection with the transaction.
$194,390.65 Proposed Common-Stock Sale Listed
J.P. Morgan Securities LLC is listed at 270 Park Ave. 10th Floor, New York, New York 10,017.
Restricted Stock Award Identified
The shares were acquired on 08/01/2025 as compensation through a Restricted Stock Award. The record also includes 400,000 common-stock shares. A separate entry lists 100,000 common-stock shares dated 06/30/2026 alongside 614,000.
FAQs
Q: How many ASP Isotopes shares does Donald George Ainscow plan to sell?
A: Donald George Ainscow plans to sell 50,000 ASP Isotopes common-stock shares under the Form 144 filing. The filing states that the proposed transaction is valued at approximately $194,390.65.
Q: Who is identified in the ASP Isotopes share-sale filing?
A: J.P. Morgan Securities LLC is identified in the ASP Isotopes transaction record. Its Workplace Solutions unit is listed as agent and attorney-in-fact for Donald George Ainscow.
Q: When did Donald George Ainscow acquire the ASP Isotopes shares?
A: The ASP Isotopes common stock was acquired on 08/01/2025. The stated acquisition method was compensation through a Restricted Stock Award.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.